Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in Metabolism
- Vol. 53 (10) , 1382-1386
- https://doi.org/10.1016/j.metabol.2004.05.013
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis: current evidence and future directionsCurrent Opinion in Lipidology, 2003
- Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Rosiglitazone reduces urinary albumin excretion in type II diabetesJournal of Human Hypertension, 2003
- ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing CholesterolCirculation, 2002
- Intima-Media Thickness of the Common Carotid Arteries Is Related to Coronary Atherosclerosis and left Ventricular Hypertrophy in Older AdultsAngiology, 2002
- Advanced atherosclerosis in predialysis patients with chronic renal failureKidney International, 2002
- The Early Effect of Lipid-lowering Treatment on Carotid and Femoral Intima Media Thickness (IMT)European Journal of Vascular and Endovascular Surgery, 2002
- Metabolic and Additional Vascular Effects of ThiazolidinedionesDrugs, 2002
- Microalbuminuria, insulin sensitivity and haemostatic factors in non-diabetic treated hypertensive menJournal of Internal Medicine, 1995